ASAM Provider Guide

National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1224390

Contents of this Issue

Navigation

Page 20 of 29

21 Figure 2. Pregnancy History • Concomitant medical conditions (hepatitis, HIV, TB, acute trauma) • Alcohol • Other substance abuse, including tobacco Laboratory • CBC, LFTs, • Hepatitis A, B & C • HIV, STIs • Confirmatory urine testing Social and Environmental Factors • Food insecurity • Housing • Transportation challenges • Domestic violence • Significant mental health issues Encourage breastfeeding (unless contraindicated) Naltrexone • Low relapse risk: consider discontinuation • Relapse risk: consider switch to buprenroprhine or methadone • Continue NTR only after discussing lack of evidence on safety and obtaining consent LEGEND Diagnosis/Evaluation Treatment Results, Notes, Status Important Comments Buprenorphine • Consider Level 3 or 4 to initiate treatment (especially in 3 rd trimester) • Dose increases may be needed • Consider split dosing Recommend prenatal care and dating ultrasound • Abdominal pain (could be preterm labor) • Bleeding • High blood pressure • Significant mental health issues • Domestic violence Identify and refer urgent problems • Hepatitis A & B vaccines (if seronegative) • HIV and TB counseling • Psychosocial treatment First Line Treatment Methadone • Start early • Consider Level 4 to initiate • Dose increases may be needed • Consider splitting the dose at least in half

Articles in this issue

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update